Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Hepatitis C, Chronic
Interventions: Drug: Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron); Drug: Drug: SCH 900518 Biologic: Peginterferon alfa-2b; Drug: Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron); Drug: Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)
Sponsor: Schering-Plough
Completed - verified March 2010
Condition: Intragastric Acidity
Interventions: Drug: Zegerid; Drug: Prilosec OTC™ Tablets; Other: Placebo
Sponsor: Schering-Plough
Completed - verified February 2010
Condition: Fungal Infection
Interventions: Drug: posaconazole; Drug: Dextrose 5% in water (1) posaconazole (2); Drug: posaconazole; Drug: posaconazole; Drug: posaconazole
Sponsor: Schering-Plough
Not yet recruiting - verified February 2010
Condition: Opioid Dependency
Interventions: Drug: Buprenorphine hydrochloride marketed sublingual tablet (Subutex); Drug: Buprenorphine hydrochloride
Sponsors: Schering-Plough; RECKITT BENCKISER
Completed - verified February 2010
All Categories ... by Company » ... Schering-Plough 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
